Zhejiang Hisun Pharmaceutical Co.,Ltd.’s Net Profit Dropped 39.3% in First Three Quarters of 2022

Zhejiang Hisun Pharmaceutical Co.,Ltd. (浙江海正药业股份有限公司) (600267.SH) reported a net profit of 338.2 million yuan in the first three quarters of 2022, down 39.3% year-on-year.

Meanwhile, the company posted 8.7 billion yuan in revenue, down 4% year-on-year.

At the end of the reporting period, it had 18.5 billion yuan in total assets and 10.5 billion yuan in total liabilities, with a liability-to-asset ratio of 56.9%.